BLCO bausch.com: Earnings growth forecast for next year

Bausch + Lomb Corporation (BLCO) is seeking to scale through the mass distribution of ophthalmology products and the automation of lens production. Market expectations for EPS growth reflect the path toward this goal, with the 25.90 mark serving as a key metric. However, post-spin-off debt and competition are creating pressure, although steady demand for equipment ensures coverage of R&D expenses.
BLCO (Bausch + Lomb): analytical breakdowns and indicator data

This indicator reflects the analysts' consensus forecast for net earnings per share growth rates, allowing for an assessment of future business efficiency through the lens of expected returns. By analyzing the forward EPS dynamics model for Bausch + Lomb Corporation (BLCO), investors can see the results of Brent Saunders' strategy regarding deleveraging and the launch of new drugs, where the upward trend confirms the success of Bausch + Lomb Corporation (BLCO) operational optimization.